Benchmark Botanics Granted “License to Sell”

Vancouver, British Columbia, Canada – September 5, 2018:

Benchmark Botanics Inc. (CSE: BBT / OTC Pink: BBHKF / FSE: BBW) (the “Company” or “Benchmark”) is pleased to announce that as of August 31, 2018, its 100% owned subsidiary, Potanicals Green Growers, Inc. (“Potanicals”), has been issued a license to sell cannabis under the Access to Cannabis for Medical Purposes Regulations (the “ACMPR”) by Health Canada.

 

“Receiving our license to sell is the crowning milestone in our licensing journey that started in 2013. This will enable the Company to showcase its products to the global market, as well as, move to close the conversations that we have engaged in thus far with vendors in several countries.” states Mr. Zhang Johnson, CEO of Benchmark.

 

The license to sell under the ACMPR will permit Potanicals to sell dried cannabis.

                               

About Benchmark

 

Benchmark is a publicly traded company based in Vancouver, British Columbia that is positioned to provide financing, partnership and acquisition opportunities to licensed producers and ancillary businesses within the global cannabis industry.

 

In November 2017, the Company acquired its first subsidiary, Potanicals Green Growers Inc. Potanicals Green Growers possesses a Health Canada license to cultivate and sell cannabis as an Access to Cannabis for Medical Purposes (ACMPR) Licensed Producer. In its first phase of operations, Potanicals is currently cultivating in its 12,700 square foot PHASE I indoor production facility. Benchmark is pursuing additional sites to retro-fit for large scale cultivation expansion.

 

ON BEHALF OF THE BOARD OF

BENCHMARK BOTANICS INC.

/s/ “Ping (Johnson) Zhang”

Ping (Johnson) Zhang

Chief Executive Officer

 

For Further Information

Investor Relations

Benchmark Botanics, Inc.

Email: invest@bbtinc.ca
Tel: 604-238-0005

www.benchmarkbotanics.com

 

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this release.

 

Forward-Looking Statements

This news release contains forward-looking statements pertaining to various risks and uncertainties regarding future events. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of the Company Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. This news release includes forward-looking statements with respect to the business and future objectives of the Company. There are numerous risks and uncertainties that could cause actual results and the Company’s plans and objectives to differ materially from those expressed in the forward-looking information, including related to: (i) the facility and Potanicals’ operations; (ii) adverse market conditions; (iii) the ability of the Company to complete financings in the future; (iv) dependence on suppliers and skilled labour; (v) government regulation and compliance with the ACMPR; (vi) managing and maintaining growth; (vii) unfavourable publicity or consumer perception litigation; and (viii) competition. Actual results could differ materially from those currently anticipated due to a number of factors and risks including the risk factors discussed in this news release and in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com and on the CSE website. These statements speak only as of the date of this news release. Except as required by law, the Company does not intend to update these forward-looking statements.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *